Lysosomal polyamine storage upon ATP13A2 loss impairs β-glucocerebrosidase via altered lysosomal pH and electrostatic hydrolase-lipid interactions

This publication has 74 references indexed in Scilit:

• PLD3 and PLD4 synthesize S,S-BMP, a key phospholipid enabling lipid degradation in lysosomes
  Cell, 2024
• Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic
  Cell, 2021
• A metabolic profile of polyamines in parkinson disease: A promising biomarker
  Annals of Neurology, 2019
• The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 2015
• A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies
  JAMA Neurology, 2013
• Pathogenic effects of novel mutations in the P‐type ATPase ATP13A2 ( PARK9 ) causing Kufor‐Rakeb syndrome, a form of early‐onset parkinsonism
  Human Mutation, 2011
• Measurement of Polyamine pK a Values
  2011
• Polyamine patterns in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy
  Clinica Chimica Acta, 2010
• Increased Red Blood Cell Polyamines in ALS and Parkinson's Disease
  Experimental Neurology, 2002
• Polyamines: Mysterious Modulators of Cellular Functions
  Biochemical and Biophysical Research Communications, 2000